Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Xiamuxiya Aisihaer"'
Autor:
Shoko Kakinuma, Minako Beppu, Setsu Sawai, Akitoshi Nakayama, Shigeki Hirano, Yoshitaka Yamanaka, Tatsuya Yamamoto, Chigusa Masafumi, Xiamuxiya Aisihaer, Alimasi Aersilan, Yue Gao, Kenichi Sato, Itoga Sakae, Takayuki Ishige, Motoi Nishimura, Kazuyuki Matsushita, Mamoru Satoh, Fumio Nomura, Satoshi Kuwabara, Tomoaki Tanaka
Publikováno v:
eNeurologicalSci, Vol 19, Iss , Pp - (2020)
Background: Dopamine replacement therapy is an established treatment for motor symptoms of Parkinson's disease, but its long-term use is often limited by the eventual development of motor complications, including levodopa-induced dyskinesia. Genetic
Externí odkaz:
https://doaj.org/article/5b288203a0f74a49a59770d6f5b37aa2
Autor:
Xiamuxiya Aisihaer1, Hongjie Guo1 hguo@antigertherapeutics.com, Chang Liu1 chang6@antigertherapeutics.com
Publikováno v:
Journal of Biological Chemistry. Sep2024, Vol. 300 Issue 9, p1-13. 13p.
Autor:
Takayuki Ishige, Shigeki Hirano, Kenichi Sato, Yoshitaka Yamanaka, Xiamuxiya Aisihaer, Tomoaki Tanaka, Fumio Nomura, Mamoru Satoh, Minako Beppu, Shoko Kakinuma, Tatsuya Yamamoto, Motoi Nishimura, Alimasi Aersilan, Yue Gao, Kazuyuki Matsushita, Itoga Sakae, Satoshi Kuwabara, Akitoshi Nakayama, Chigusa Masafumi, Setsu Sawai
Publikováno v:
eNeurologicalSci
eNeurologicalSci, Vol 19, Iss, Pp-(2020)
eNeurologicalSci, Vol 19, Iss, Pp-(2020)
Background Dopamine replacement therapy is an established treatment for motor symptoms of Parkinson's disease, but its long-term use is often limited by the eventual development of motor complications, including levodopa-induced dyskinesia. Genetic b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e61e462fad62ccc78261cb3af294a54
https://pubmed.ncbi.nlm.nih.gov/32346620
https://pubmed.ncbi.nlm.nih.gov/32346620